27 Jul 2010 07:00
SYNAIRGEN PLC
NOTICE OF RESULTS
Synairgen plc (LSE: SNG), the respiratory drug discovery and development company with a particular focus on viral defences will be announcing its full year results for the year ended 30 June 2010 on Thursday 29 July 2010.
Ends
For further information, please contact:
Synairgen | Tel: + 44 (0) 2380 512 800 |
Richard Marsden, Chief Executive Officer John Ward, Finance Director or email info@synairgen.com
| |
Threadneedle Communications Tel: + 44 (0) 20 7653 9850 Graham Herring |
graham.herring@threadneedlepr.co.uk